Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy

Michael Friedlander; Ursula Matulonis; Charlie Gourley; Andreas Du Bois; Ignace Vergote; Gordon Rustin; Clare Scott; Werner Meier; Ronnie Shapira-frommer; Tamar Safra; Daniela Matei; Vadim Shirinkin; Frédéric Selle; Anitra Fielding; Elizabeth S. Lowe; Emma L. Mcmurtry; Stuart Spencer; Philip Rowe; Helen Mann; David Parry; Jonathan Ledermann

doi:10.1038/s41416-018-0271-y

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy

Michael Friedlander, Ursula Matulonis, Charlie Gourley, Andreas Du Bois, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-frommer, Tamar Safra, Daniela Matei, Vadim Shirinkin, Frédéric Selle, Anitra Fielding, Elizabeth S. Lowe, Emma L. Mcmurtry, Stuart Spencer, Philip Rowe, Helen Mann, David ParryJonathan Ledermann

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	British Journal of Cancer
Early online date	24 Oct 2018
DOIs	https://doi.org/10.1038/s41416-018-0271-y
Publication status	E-pub ahead of print - 24 Oct 2018

Access to Document

10.1038/s41416-018-0271-y

Friedlander et al. Long term efficacy_BJC 2018Final published version, 694 KBLicence: Creative Commons: Attribution (CC-BY)

http://www.nature.com/articles/s41416-018-0271-y

Cite this

Friedlander, M., Matulonis, U., Gourley, C., Du Bois, A., Vergote, I., Rustin, G., Scott, C., Meier, W., Shapira-frommer, R., Safra, T., Matei, D., Shirinkin, V., Selle, F., Fielding, A., Lowe, E. S., Mcmurtry, E. L., Spencer, S., Rowe, P., Mann, H., ... Ledermann, J. (2018). Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy. British Journal of Cancer. Advance online publication. https://doi.org/10.1038/s41416-018-0271-y

@article{e28905f438d542dd860cb28a2d986009,

title = "Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy",

author = "Michael Friedlander and Ursula Matulonis and Charlie Gourley and \{Du Bois\}, Andreas and Ignace Vergote and Gordon Rustin and Clare Scott and Werner Meier and Ronnie Shapira-frommer and Tamar Safra and Daniela Matei and Vadim Shirinkin and Fr{\'e}d{\'e}ric Selle and Anitra Fielding and Lowe, \{Elizabeth S.\} and Mcmurtry, \{Emma L.\} and Stuart Spencer and Philip Rowe and Helen Mann and David Parry and Jonathan Ledermann",

year = "2018",

month = oct,

day = "24",

doi = "10.1038/s41416-018-0271-y",

language = "English",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

}

Friedlander, M, Matulonis, U, Gourley, C, Du Bois, A, Vergote, I, Rustin, G, Scott, C, Meier, W, Shapira-frommer, R, Safra, T, Matei, D, Shirinkin, V, Selle, F, Fielding, A, Lowe, ES, Mcmurtry, EL, Spencer, S, Rowe, P, Mann, H, Parry, D & Ledermann, J 2018, 'Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy', British Journal of Cancer. https://doi.org/10.1038/s41416-018-0271-y

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy. / Friedlander, Michael; Matulonis, Ursula; Gourley, Charlie et al.
In: British Journal of Cancer, 24.10.2018.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy

AU - Friedlander, Michael

AU - Matulonis, Ursula

AU - Gourley, Charlie

AU - Du Bois, Andreas

AU - Vergote, Ignace

AU - Rustin, Gordon

AU - Scott, Clare

AU - Meier, Werner

AU - Shapira-frommer, Ronnie

AU - Safra, Tamar

AU - Matei, Daniela

AU - Shirinkin, Vadim

AU - Selle, Frédéric

AU - Fielding, Anitra

AU - Lowe, Elizabeth S.

AU - Mcmurtry, Emma L.

AU - Spencer, Stuart

AU - Rowe, Philip

AU - Mann, Helen

AU - Parry, David

AU - Ledermann, Jonathan

PY - 2018/10/24

Y1 - 2018/10/24

U2 - 10.1038/s41416-018-0271-y

DO - 10.1038/s41416-018-0271-y

M3 - Article

SN - 0007-0920

JO - British Journal of Cancer

JF - British Journal of Cancer

ER -

Friedlander M, Matulonis U, Gourley C, Du Bois A, Vergote I, Rustin G et al. Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy. British Journal of Cancer. 2018 Oct 24. Epub 2018 Oct 24. doi: 10.1038/s41416-018-0271-y